Global Expansion Glatt is a worldwide leader in fluidized bed technology with 14 branches and subsidiaries, creating opportunities to cross-sell integrated process solutions across regions and leverage global service capabilities for multinational pharma and chemical clients.

Pharma Focus Core expertise in Process Technology Pharma, including fluidized beds and solid dosage form development, positions Glatt to pursue increased collaborations with pharmaceutical manufacturers seeking end-to-end solutions from development to plant installation.

New Capabilities Recent launches of GSX and GSX.Lab spray drying technologies at Interpack and related events indicate a drive to upgrade manufacturing capabilities; opportunities exist to target mid-market and large pharma with advanced spray drying and coater GCC offerings.

Strategic Partnerships Partnership with PreferCo to establish a Bioprocess Scale-Up Centre of Excellence in India signals a channel and co-development path for bioprocess clients, suggesting potential joint opportunities in biosimilars, vaccines, and biotech manufacturing.

End-to-End Solutions Glatt’s combined strengths across Process Technology, Pharmaceutical Services, Food/Feed & Fine Chemicals, and Process & Plant Engineering enable selling integrated projects that cover development, scale-up, process optimization, and turnkey plant construction for new or reconfigured facilities.